Sotac Pharma.
Nav Capital decreased its stake in Sotac Pharma from 7.35% to 7.07%, selling 31,200 shares.
A pharmaceutical manufacturer operating in India, Sotac Pharma produces and distributes a comprehensive range of pharmaceutical products across multiple therapeutic categories and treatment areas. Founded in 2015, the company engages in formulation development, active pharmaceutical ingredient sourcing, manufacturing operations, and distribution of medicines. It serves both domestic Indian markets and international customers through its established supply chains and regulatory compliance frameworks.
Nav Capital is an India-focused investment platform whose Nav Capital VCC Emerging Star Fund is among the most active foreign portfolio investors anchoring Indian SME IPOs. It pursues high-conviction investing across private and public markets.